Ad
Four-in-five AstraZeneca doses remained unused across Europe more than two weeks following their delivery (Photo: European Commission)

What Estonia and Slovakia did to beat AstraZeneca 'hesitancy'

European populaces are increasingly expressing frustration both towards the stringent lockdowns that have constrained their lives and sluggish inoculation programmes that have tested their patience.

The EU's Covid-19 vaccine supply is indeed forecast to amount to as few as 100 million doses by the end of March. This number pales in comparison to ...

Get EU news that matters

Back our independent journalism by becoming a supporting member

Already a member? Login here

Disclaimer

The views expressed in this opinion piece are the author’s, not those of EUobserver

Author Bio

Shane Markowitz is an associate fellow at the GLOBSEC Policy Institute in Bratislava. His writing has been published in The Washington Post, World Politics Review, EUobserver, Social Europe, openDemocracy, and the journal Populism.

Four-in-five AstraZeneca doses remained unused across Europe more than two weeks following their delivery (Photo: European Commission)

Tags

Author Bio

Shane Markowitz is an associate fellow at the GLOBSEC Policy Institute in Bratislava. His writing has been published in The Washington Post, World Politics Review, EUobserver, Social Europe, openDemocracy, and the journal Populism.

Ad

Related articles

Ad
Ad